H.R. 304 · 115th Congress
Protecting Patient Access to Emergency Medications Act of 2017
Law · 115-83Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
25 cosponsors · 13 D, 12 R
19 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Jan 5, 2017
- House Passed Jan 9, 2017 404–0
- Senate Passed Oct 24, 2017
- House Changes resolved Nov 2, 2017
- President To the President Nov 7, 2017
- President Signed Nov 17, 2017
Protecting Patient Access to Emergency Medications Act of 2017
What it does: CRS summary · Public Law · Nov 17, 2017
Protecting Patient Access to Emergency Medications Act of 2017
(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.
An EMS agency may obtain a single registration in each state instead of a separate registration for each location.
A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.
An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.
The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
Votes to become law
About this bill and sources
Official title: Protecting Patient Access to Emergency Medications Act of 2017
Latest action (Nov 17, 2017): Signed by President.
Policy area: Health · Origin: House · Introduced: Jan 5, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
- House Introduced Jan 5, 2017
- House Passed Jan 9, 2017 404–0
- Senate Passed Oct 24, 2017
- House Changes resolved Nov 2, 2017
- President To the President Nov 7, 2017
- President Signed Nov 17, 2017
Final vote · House · Jan 9, 2017
Passage (two-thirds required) — Passed. Vote details
Speaker of the House: Paul D. Ryan